PRECIGEN, INC. — Director's Dealing 2020

Jan 7, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTREXON CORP (XON)
CIK: 0001356090
Period of Report: 2020-01-04

Reporting Person: Reed Thomas D. (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-04	Common Stock	M	18940	—	Acquired	154304	Direct
2020-01-06	Common Stock	S	5416	$5.8293	Disposed	148888	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-04	Restricted Stock Units	$	M	18940	Disposed		Common Stock (18940)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	62840	Indirect
Common Stock	41705	Indirect
Common Stock	2440	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of XON common stock.

F2: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.

F3: Held by the Thomas David Reed Living Trust dated February 4, 2011.

F4: Held by the Jacquelyn Ann Reed Living Trust dated February 4, 2011.

F5: The restricted stock units were granted on January 4, 2019, and the remaining restricted stock units vest in three equal annual installments on each of January 4, 2021, 2022 and 2023.